Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

1 abstract

Abstract
Lenalidomide-based monotherapy versus augmented therapy for maintenance in standard risk multiple myeloma patients with no complete response post autologous hematopoietic cell transplantation.
Org: Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland, OH, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH,